Treatment of attention deficit disorder with DL-phenylalanine

[1]  P. Wender,et al.  A controlled study of Methylphenidate in the treatment of Attention Deficit Disorder, Residual Type, in Adults , 1985, The American journal of psychiatry.

[2]  J. Rapoport,et al.  Urinary phenethylamine response to d-amphetamine in 12 boys with attention deficit disorder. , 1984, The American journal of psychiatry.

[3]  P. Wender,et al.  An open trial of pargyline in the treatment of attention deficit disorder, residual type , 1983, Psychiatry Research.

[4]  A. Halaris,et al.  Biological studies in adult attention deficit disorder: case report. , 1982, The Journal of clinical psychiatry.

[5]  W. S. Appleton.  Fourth psychoactive drug usage guide. , 1982, The Journal of clinical psychiatry.

[6]  P. Wender,et al.  Effects of levodopa on attention deficit disorder, residual type , 1982, Psychiatry Research.

[7]  P. Wender,et al.  Attention deficit disorder ('minimal brain dysfunction') in adults. A replication study of diagnosis and drug treatment. , 1981, Archives of general psychiatry.

[8]  J. Mann,et al.  D-phenylalanine in endogenous depression. , 1980, The American journal of psychiatry.

[9]  R. Wurtman,et al.  Precursor control of neurotransmitter synthesis. , 1980, Pharmacological reviews.

[10]  R. Bodnar,et al.  Antagonism of stress-induced analgesia by D-phenylalanine, an anti-enkephalinase , 1980, Pharmacology Biochemistry and Behavior.

[11]  J. Deveaugh-Geiss,et al.  Paradoxical response to amphetamine in a hyperkinetic adult. , 1980, Psychosomatics.

[12]  L. Judd,et al.  Adult minimal brain dysfunction and schizophrenia: a case report. , 1978, The American journal of psychiatry.

[13]  S. Packer.  Treatment of Minimal Brain Dysfunction in a Young Adult* , 1978, Canadian Psychiatric Association journal.

[14]  P. Wender,et al.  Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report. , 1976, Archives of general psychiatry.

[15]  T. Chase,et al.  Central monoamines and hyperkinesis of childhood , 1976, Neurology.

[16]  S. Greenspan,et al.  The identification and treatment of adult brain dysfunction. , 1976, The American journal of psychiatry.

[17]  R. Borison,et al.  Brain 2-phenylethylamine as a major mediator for the central actions of amphetamine and methylphenidate. , 1975, Life sciences.

[18]  K. Minkoff,et al.  Explosive personality as a sequel to the hyperactive-child syndrome. , 1975, Comprehensive psychiatry.

[19]  R. Borison,et al.  Biosynthesis of brain 2-phenylethylamine: influence of decarboxylase inhibitors and D-amphetamine. , 1974, Life sciences.

[20]  A. Riester,et al.  Syndrome of minimal brain damage in young adults. , 1972, Diseases of the nervous system.

[21]  G. Glaser,et al.  The syndrome of "minimal brain damage" in childhood. , 1966, New England Journal of Medicine.

[22]  S. Siegel,et al.  Nonparametric Statistics for the Behavioral Sciences , 2022, The SAGE Encyclopedia of Research Design.

[23]  E. Denhoff,et al.  Hyperkinetic behavior syndrome in children. , 1957, The Journal of pediatrics.

[24]  E. W. Taylor.  Archiv für Psychiatrie and Nervenkrankheiten , 1911 .

[25]  W. R. Brain.  Diseases of the Nervous System , 1892, Buffalo Medical and Surgical Journal.

[26]  P. Wender,et al.  The use of L-deprenyl in the treatment of attention deficit disorder, residual type , 1983 .

[27]  L. Small.  The minimal brain dysfunctions: Diagnosis and treatment , 1982 .

[28]  R. Balagot,et al.  FURTHER STUDIES ON THE ANALGESIC ACTIVITY OF D-PHENYLALANINE (DPA) IN MICE AND HUMANS , 1980 .

[29]  B. Roberts.  A computerized diagnostic evaluation of a psychiatric problem. , 1980, The American journal of psychiatry.

[30]  P. Wender,et al.  An open clinical trial of L-dopa and carbidopa in adults with minimal brain dysfunction. , 1980, The American journal of psychiatry.

[31]  B. Shaywitz,et al.  CSF monoamine metabolites in children with minimal brain dysfunction: evidence for alteration of brain dopamine. A preliminary report. , 1977, The Journal of pediatrics.

[32]  H. Spatz,et al.  Therapy of depression by phenylalanine. Preliminary note. , 1975, Arzneimittel-Forschung.

[33]  C. M. Anderson.  Minimal brain damage. , 1972, Mental hygiene.